Mode
Text Size
Log in / Sign up
N/A N=34 Randomized Double-blind Treatment

Depression and Pain Perseverance Through Empowered Recovery Intervention

Pain · Depressive Symptoms · Frailty · Aging

Enrolled (actual)
34
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcome: Primary: Pain Intensity as Assessed by the Patient Reported Outcomes Measurement Information System (PROMIS) — 6.75; 7.29; 6.64; 7.00 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
DAPPER (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
Female
Sponsor
Johns Hopkins University
Primary completion
Nov 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Intensity as Assessed by the Patient Reported Outcomes Measurement Information System (PROMIS)
6.75; 7.29; 6.64; 7.00
PRIMARY
Depressive Symptoms as Assessed by the Patient Health Questionnaire 9 (PHQ-9)
12.25; 11.53; 8.36; 11.43
SECONDARY
Interleukin (IL)-6 in Saliva (pg/ml)
7.97; 8.19; 5.12; 7.54
SECONDARY
Interleukin (IL)-8 in Saliva (pg/ml)
1780.22; 2847.77; 1305.79; 1805.99
SECONDARY
Interleukin (IL)-1 Beta in Saliva (pg/ml)
154.7; 564.35; 247.47; 347.73
SECONDARY
Tumor Necrosis Factor (TNF)-Alpha in Saliva (pg/ml)
5.09; 7.66; 3.56; 4.68

Summary

African American women who are 50 years of age and older with depressive symptoms, pain and difficulty with mobility will participate in the DAPPER intervention study that includes 8 nurse visits in participants' homes to help participants with participants' pain and mood.

Eligibility Criteria

Inclusion Criteria

  • Self-report pain >3 out of a 0 -10 scale that has lasted longer than 3 months and keeps subjects from doing at least one activity that subjects would like to do
  • Self-Identify as African American/Black female
  • Live in a community dwelling
  • Score a 5 or higher on the PHQ-9 (depression measure) at least two times during a two week period (screening call and then at first data collection visit)
  • Must be pre-frail (one or two criteria on frailty phenotype) or frail (three or more of the criteria on frailty phenotype)
  • One ADL or IADL limitation

Exclusion Criteria

  • Hospitalized > 3 times in the last year
  • Participating in physical therapy
  • Have a terminal diagnosis ( moderate intellectual impairment (5-7 errors) based on the Short Portable Mental Status Questionnaire (SPMSQ)
  • Unable to speak or understand English
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04091347). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search